Cardoso Pedro, Santos C, Rocha-Gonçalves Francisco
Luz Saúde, Lisbon, Portugal.
Faculty of Medicine, University of Porto, Porto, Portugal.
Glob J Qual Saf Healthc. 2020 May 21;3(2):69-71. doi: 10.36401/JQSH-19-40. eCollection 2020 May.
Therapeutic drug monitoring (TDM) has as its main objective to ensure that the plasma drug concentration remains within the appropriate range. Regarding the economic dimension of TDM, it is known that there are gains in health outcomes; however, there is still little evidence for the benefit of this procedure performed by pharmacists within the hospital context. With this project, we aimed to create a matrix of cost avoidance associated with TDM performed by pharmacists and to quantify the total avoided costs in 1 year, by implementing a TDM process in a tertiary hospital. For the studied period, we collected 362 pharmaceutical interventions related to TDM of antibiotics performed in adults. As a result, considering these data, the total cost avoidance in 1 year was 371,018 ($416,584.58) at one medical center. We conclude that TDM is highly cost-avoidant and that the implementation costs by pharmaceutical services is clearly lower than the benefit achieved.
治疗药物监测(TDM)的主要目标是确保血浆药物浓度保持在适当范围内。关于TDM的经济层面,已知其在健康结果方面有收益;然而,在医院环境中由药剂师执行该程序的益处仍缺乏证据。通过这个项目,我们旨在创建一个与药剂师执行的TDM相关的成本避免矩阵,并通过在一家三级医院实施TDM流程来量化一年内避免的总成本。在研究期间,我们收集了362项与成人抗生素TDM相关的药学干预措施。结果,考虑到这些数据,一个医疗中心一年内避免的总成本为371,018美元(416,584.58美元)。我们得出结论,TDM具有很高的成本避免效益,并且药学服务的实施成本明显低于所实现的效益。